The U.S. Food and Drug Administration (FDA) has accepted Genentech’s supplemental Biologics License Application for Gazyva® ...
An estimated 8% of Americans live with autoimmune diseases that cause chronic inflammation and damage. Now, a breakthrough ...
The Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) for obinutuzumab for the treatment of systemic lupus erythematosus (SLE). Findings ...
The U.S. Food & Drug Administration (FDA) has granted approval for subcutaneous administration of anifrolumab (SAPHNELO) for ...
That’s what the autoimmune disease lupus does, 1 and when it strikes, it can cause significant symptoms, including extreme ...
Researchers are looking into whether a breakthrough cancer therapy is the missing piece that could treat autoimmune diseases.
AstraZeneca’s SAPHNELO ® (anifrolumab-fnia) has been approved in the US for self-administration as a once-weekly autoinjector, the SAPHNELO Pen , for the treatment of adult patients with systemic ...
Merck, a leading global science and technology company, today announced the first patient was dosed in the Phase 3 program, ...
NEW YORK, Nov. 25, 2025 /PRNewswire/ -- The Lupus Research Alliance, the largest private funder of lupus research, hosted its annual Breaking Through Gala – raising over $2.8 million to help free the ...
Medicare covers treatment that you may need following a lupus diagnosis. Depending on your age, it may also cover tests and consultations leading up to diagnosis. Out-of-pocket costs will apply. Lupus ...
Kidney damage is a serious complication affecting individuals with lupus, an autoimmune disease where immune B cells ...
Lupus cystitis is a rare complication of systemic lupus erythematosus (SLE). It can cause symptoms such as increased urination, the sudden need to urinate, pain during urination, and lower abdominal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results